Cupps Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Cupps Capital Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$1K	Buy	+3	New	+$1.2K	﹤0.01%	176
2014 Q2	–	Sell	-7,634	Closed	-$2.29M	–	235
2014 Q1	$2.29M	Sell	7,634 -9,852	-56%	-$3.04M	0.18%	122
2013 Q4	$4.81M	Sell	17,486 -7,971	-31%	-$2.29M	0.33%	91
2013 Q3	$7.96M	Buy	25,457 +6,813	+37%	+$1.79M	0.52%	64
2013 Q2	$4.19M	Buy	+18,644	New	+$4.34M	0.33%	77

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Cupps Capital Management's REGN Position: Q3 2016 in Review

Cupps Capital Management opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2016: 3 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #176 among its holdings. This is a return to the name: Cupps Capital Management previously reported a position in REGN as recently as Q1 2014.

Cupps Capital Management first reported a position in REGN in Q2 2013 and has held it in 5 quarters since. The position peaked at $7.96M in Q3 2013. 555 funds tracked by Wall St. Rank hold REGN as of Q3 2016.

Cupps Capital Management held 3 shares of Regeneron Pharmaceuticals worth $1K as of Q3 2016.
Regeneron Pharmaceuticals was a new Cupps Capital Management position in Q3 2016.
Regeneron Pharmaceuticals made up ﹤0.01% of Cupps Capital Management's portfolio in Q3 2016, its #176 holding.
Cupps Capital Management first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 5 quarters since.
Cupps Capital Management's Regeneron Pharmaceuticals position peaked at $7.96M in Q3 2013.
555 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2016.

Based on Cupps Capital Management's 13F filing for Q3 2016, filed 11 Oct 2016.